While BMP2 promotes differentiation in glioma stem-like cells under specific conditions, its upregulation in bulk tumor tissue—as observed here—may instead reflect a non-functional or dysregulated compensatory response, possibly driven by an immunosuppressive or mesenchymal microenvironment. Here, BMP2 is linked to central nervous system cancer.